HIGHLIGHTS
- who: Federico Pratesi from the Complutense University of Madrid, Spain have published the Article: A SARSu2013CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients, in the Journal: (JOURNAL)
- what: The construct used in this work had the D614G mutation shared by most of the SARS- May 2022 | Volume 13 | Article 879946 Anti-Spike RBM Antibodies in COVID-19 CoV-2 variant of concern (B.1.1.7 - Alpha, B.1.351 - Beta, B.1.617.2 - Delta, B.1.1.529 - Omicron) widely spread during . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.